In addition, by analyzing the clinical-pathophysiological characteristics of GBC patients with high and low TRPM2-AS expression, we found that patients with high TRPM2-AS expression tended to have a larger tumor size, higher CA19-9 levels, higher rates of lymph node metastasis, liver invasion, lower tumor differentiation, and later tumor node metastasis (TNM) stages (Table S5). The gene discussed is TRPM2; the disease is neoplasm.